Boulton I C, Gorringe A R, Allison N, Robinson A, Gorinsky B, Joannou C L, Evans R W
Metalloprotein Research Group, Division of Biochemistry and Molecular Biology, United Medical and Dental School of Guy's and St. Thomas's Hospitals, Guy's Hospital, London SE1 9RT, U.K.
Biochem J. 1998 Aug 15;334 ( Pt 1)(Pt 1):269-73. doi: 10.1042/bj3340269.
Neisseria meningitidis utilization of human serum transferrin (hTF)-bound iron is an important pathogenicity determinant. The efficiency of this system would clearly be increased through preferential binding of diferric hTF over the iron-free form. To characterize this process, functionally active meningococcal transferrin-binding protein A (TbpA) and TbpB have been purified from N. meningitidis using a novel purification procedure. The association of isolated Tbps and Tbps in the presence of hTF was investigated by gel filtration. Co-purified TbpA+B formed a complex of molecular mass 300 kDa which bound 1-2 molecules of hTF. Purified TbpA formed a complex of 200 kDa, indicating association as a dimer, whereas TbpB aggregated to form multimers of variable sizes. On recombining TbpA and TbpB, a stable complex of equivalent size to co-purified TbpA+B was formed. This complex may be composed of a single TbpA dimer and 1 molecule of TbpB. The technique of surface plasmon resonance (SPR) was used to demonstrate clearly that TbpB of either high (85 kDa) or low (68 kDa) molecular-mass preferentially bound diferric hTF in comparison with iron-free hTF. This selectivity was not observed with TbpA, but was found at low levels with co-purified TbpA+B. Individual TbpA and TbpB, recombined in a 1:1 molecular ratio, showed iron-mediated discriminatory binding at an intermediate level. SPR was also used to show that TbpA and TbpB bound to distinct regions of hTF, and that prior saturation with TbpB reduced subsequent TbpA binding. The results demonstrated that hTF bound more TbpA than TbpB, with an approximate ratio of 2:1. We have demonstrated that in vitro, TbpA+B exists as a receptor complex composed of a TbpA dimer and one molecule of TbpB, and that TbpB selectively binds diferric hTF. We propose that, in vivo, TbpA and TbpB also exist as a receptor complex, with TbpB selectively binding diferric hTF, bringing it close to TbpA, the transmembrane component, where the ferric iron can be transported to the periplasm.
脑膜炎奈瑟菌利用人血清转铁蛋白(hTF)结合的铁是一个重要的致病性决定因素。通过二价铁hTF比无铁形式的优先结合,该系统的效率显然会提高。为了表征这一过程,已使用一种新型纯化程序从脑膜炎奈瑟菌中纯化出功能活性的脑膜炎球菌转铁蛋白结合蛋白A(TbpA)和TbpB。通过凝胶过滤研究了分离的Tbps与hTF存在下的Tbps的结合情况。共纯化的TbpA + B形成了分子量为300 kDa的复合物,该复合物结合了1 - 2分子的hTF。纯化的TbpA形成了200 kDa的复合物,表明以二聚体形式结合,而TbpB聚集形成大小可变的多聚体。在重组TbpA和TbpB时,形成了与共纯化的TbpA + B大小相当的稳定复合物。该复合物可能由单个TbpA二聚体和1分子TbpB组成。表面等离子体共振(SPR)技术被用于清楚地证明,与无铁hTF相比,高分子量(85 kDa)或低分子量(68 kDa)的TbpB优先结合二价铁hTF。TbpA未观察到这种选择性,但在共纯化的TbpA + B中发现了低水平的选择性。以1:1分子比重组的单个TbpA和TbpB在中等水平上显示出铁介导的歧视性结合。SPR还用于表明TbpA和TbpB结合到hTF的不同区域,并且用TbpB预先饱和会降低随后的TbpA结合。结果表明,hTF结合的TbpA比TbpB多,近似比例为2:1。我们已经证明,在体外,TbpA + B作为由TbpA二聚体和一分子TbpB组成的受体复合物存在,并且TbpB选择性地结合二价铁hTF。我们提出,在体内,TbpA和TbpB也作为受体复合物存在,TbpB选择性地结合二价铁hTF,使其靠近跨膜成分TbpA,在那里三价铁可以被转运到周质中。